Immunopathogenesis of severe pneumonia in children with emphasis on CD4+ T cells, Tim-3 and cytokine-mediated immune dysregulation.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
Severe pneumonia in children remains a major cause of hospitalization, respiratory failure and infection-related mortality. Increasing evidence indicates that disease severity is shaped not only by pathogen burden but also by the timing, intensity and compartmentalization of the host immune response. CD4+ T cells are central to this process because they coordinate macrophage activation, B-cell help, mucosal defense and immune resolution. In severe disease, however, CD4+ T-cell responses may become depleted, misdirected or constrained by immune-checkpoint pathways. T-cell immunoglobulin and mucin-domain-containing protein 3 (Tim-3/HAVCR2) is a context-dependent immune regulator that may reflect activation, adaptive restraint, regulatory compensation or exhaustion-like dysfunction depending on disease phase and inflammatory milieu. In parallel, cytokines such as interleukin (IL)-6, IL-8, IL-1β and tumor necrosis factor-α amplify neutrophilic inflammation, endothelial activation, vascular leakage and systemic injury. This narrative review synthesizes current evidence on CD4+ T-cell dysfunction, Tim-3 biology and cytokine-mediated immune dysregulation in severe pediatric pneumonia. We propose a checkpointed hyperinflammation framework in which innate cytokine amplification coexists with constrained adaptive immune coordination. However, direct pediatric pneumonia evidence remains limited, and much of the mechanistic interpretation of Tim-3 is extrapolated from adult sepsis, oncologic, chronic infection and autoimmune literature. CD4+Tim-3, soluble Tim-3, and focused cytokine panels therefore can be evaluated in longitudinal pediatric cohorts with pathogen stratification, multi-checkpoint profiling, and blood-airway immune comparison.